Dublin, February 03rd 2020, For the third year running, Shimmer a leading provider of medical grade wearable wireless sensors has been selected as the partner of choice for Ipsos’ annual study measuring an audience’s nonconscious, real-time response to all the advertisements during the 2020 Super Bowl.
Taking place in New York City on the evening of February 02nd, 2020, each of the 40 participants wore the NeuroLynQ sensor for the full duration of the game which was just under four hours in length. The NeuroLynQ sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a real time read on the whole audience’s responses. At a glance, Ipsos could focus on an individual’s response or report on the percentage of the audience that was having a response.
Ipsos used NeuroLynQ to measure the nonconscious response of the audience to every commercial throughout the game, aired in the NYC area and rank the different ads accordingly. The data was used to decode which ads had the strongest emotional impact on the audience during the event itself, including the context of the big game – a very different methodology to most rankings, which test ads in isolation. Their results are ranked here:
According to Pedr Howard, from Ipsos Creative Excellence: “We believe this is a markedly different ranking system to most used in the industry, for two reasons: first it is entirely based on passive measurement, passive reactions; second, it was collected during the event itself, reflecting the real-world response and context around the Super Bowl.”
Click Here for the full Ipsos Press Release
For more information on this news release or the NeuroLynQ solution, please click here or contact:
USA – Geoffrey Gill, [email protected], (617) 945- 2628
Ireland – Martina Donohue, [email protected], + 353 1 6875760
Lisa Osborne, Rana Healthcare Solutions, +1 (206) 992-5245, [email protected]
About Shimmer Research:
Shimmer is a leading technology company providing clinical-grade wearable wireless sensing technology. The company’s award-winning platform enables enterprises to reduce risk, cost, and time to market for sensor-based digital health solutions. Shimmer Research offers consultancy, design, customization, and volume manufacture for a full range of wearable sensor technology to provide high quality, scientifically reliable biophysical and movement data in real time with the goal of improving healthcare outcomes. Shimmer’s technology is trusted and utilized by the world’s brightest startups, Fortune 500 companies, and leading universities in more than 65 countries worldwide. Established in 2008, Shimmer has its headquarters in Dublin, Ireland. For more information visit: www.shimmersensing.com